Clear Street Markets LLC Edwards Lifesciences Corp Transaction History

Clear Street Markets LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $145 - $191	2 New	2 $0
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $34,110 - $39,524	-419 Reduced 34.57%	793 $75,000
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $255,677 - $290,967	-3,443 Reduced 73.96%	1,212 $100,000
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $221,565 - $283,655	3,244 Added 229.91%	4,655 $347,000
Q3 2022 Nov 02, 2022	BUY	$82.37 - $107.29 $9,225 - $12,016	112 Added 8.62%	1,411 $117,000
Q2 2022 Aug 02, 2022	BUY	$86.5 - $128.27 $90,219 - $133,785	1,043 Added 407.42%	1,299 $124,000
Q1 2022 May 11, 2022	BUY	$101.96 - $128.34 $26,101 - $32,855	256 New	256 $30,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.